Skip to main content

Table 4 Prognostic value of NUCB2 protein expression for the overall survival in univariate and multivariate analyses by Cox regression

From: Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer

Covariant Univariate analysis Multivariate analysis
Exp (B) 95% CI P value Exp (B) 95% CI P value
NUCB2 protein expression (high/low) 2.978 1.516-6.181 <0.001 3.152 1.317-6.214 <0.001
Gleason score (> 7/7/< 7) 2.526 1.788-3.568 <0.001 2.014 1.217-2.869 <0.001
PSA (>10/4-10/< 4) 2.034 1.338-23.092 0.001 1.989 1.292-3.053 <0.001
Age (≥65/< 65) 1.282 0.917-1.792 0.146    
Angiolymphatic invasion (presence/absence) 1.373 0.813-2.319 0.235    
Surgical margin status (presence/absence) 1.101 0.703-1.724 0.674    
PCa Stage (T2, T3/T1) 4.131 2.888-5.911 <0.001 3.671 2.656-5.715 <0.001
Lymph node metastasis (presence/absence) 1.044 0.746-1.462 0.800    
Seminal vesicle invasion (presence/absence) 1.358 0.956-1.928 0.087